Filing Details

Accession Number:
0000899243-18-002043
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-25 20:09:24
Reporting Period:
2018-01-23
Accepted Time:
2018-01-25 20:09:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1629137 Global Blood Therapeutics Inc. GBT Pharmaceutical Preparations (2834) 274825712
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650131 Peter Radovich C/O Global Blood Therapeutics, Inc.
171 Oyster Point Blvd., Suite 300
South San Francisco CA 94080
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-23 30,000 $1.61 33,581 No 4 M Direct
Common Stock Disposition 2018-01-23 30,000 $60.00 3,581 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-01-23 30,000 $0.00 30,000 $1.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,000 2025-01-20 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. 25% of the shares subject to this option vested and became exercisable on November 17, 2015, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter.